Why Is OMNICELL INC (OMCL) Stock Up Today?

OMCL stock rose 6.29% to $35.16 on Friday, driven by a series of upcoming investor-facing events and revised guidance from the company. Omnicell Inc is set to present at the Wells Fargo 21st Annual Healthcare Conference on Sept. 9 and has scheduled a meeting with Piper Sandler. These developments follow recent analyst revisions and updated earnings forecasts, which have sparked renewed investor interest.

What Happened

Omnicell announced it will present at the Wells Fargo Healthcare Conference on Sept. 9 at 12:45 p.m. EDT. The presentation will be streamed live and archived on the company’s website. Separately, management is scheduled to meet with Piper Sandler, signaling increased engagement with key analysts. These events come amid a backdrop of recent analyst activity. Piper Sandler and Wells Fargo both reiterated Overweight ratings for Omnicell, while Keybanc also maintained its Overweight stance. Meanwhile, the company issued revised Q3 guidance, projecting adjusted EPS of $0.35 to $0.43 and sales of $301 million to $307 million. Omnicell also raised its FY2026 adjusted EPS guidance to $2.15 to $2.30 and narrowed its sales forecast to $1.225 billion to $1.245 billion.

What The Data Shows

Omnicell’s stock traded at $35.16, up 6.29% for the session, with a market cap of $1.5 billion. The stock closed within its 52-week range of $29.06 to $55.00. On the 52-week tape, the stock printed 40 fresh 52-week highs and two fresh 52-week lows on Aug. 31. Recent insider transactions include two sales totaling $584,000, with the most recent filing on Aug. 18. The company’s fundamentals include a P/E ratio of 39.3, revenue growth of 8.5% trailing twelve months, and a net margin of 3.1%.

What To Watch

Investors should monitor the Sept. 9 presentation at the Wells Fargo Healthcare Conference and the scheduled meeting with Piper Sandler for potential updates on the company’s strategic direction and financial outlook.